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A B S T R A C T
Objectives: The risk of acquisition and transmission of respiratory infections is high among attendees of
mass gatherings (MGs). Currently used interventions have limitations yet the role of facemask in
preventing those infections at MG has not been systematically reviewed. We have conducted a
systematic review to synthesise evidence about the uptake and effectiveness of facemask against
respiratory infections in MGs.
Methods: A comprehensive literature search was conducted according to the preferred reporting items
for systematic reviews and meta-analyses (PRISMA) guidelines using major electronic databases such as,
Medline, EMBASE, SCOPUS and CINAHL.
Results: Of 25 studies included, the pooled sample size was 12710 participants from 55 countries aged
11 to 89 years, 37% were female. The overall uptake of facemask ranged from 0.02% to 92.8% with an
average of about 50%. Only 13 studies examined the effectiveness of facemask, and their pooled estimate
revealed signiﬁcant protectiveness against respiratory infections (relative risk [RR] = 0.89, 95% CI: 0.84-
0.94, p < 0.01), but the study end points varied widely.
Conclusion: A modest proportion of attendees of MGs use facemask, the practice is more widespread
among health care workers. Facemask use seems to be beneﬁcial against certain respiratory infections at
MGs but its effectiveness against speciﬁc infection remains unproven.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
The risk of acquisition and transmission of respiratory
infections ampliﬁes at mass gatherings (MGs) straining healthcare
of the host country. For instance, in Hajj, one of the largest annual
MG events in the world, more than 2 million people attend each
year in Makkah, and over 90% suffer from at least one respiratory
symptom, the risk of viral respiratory infections increases several
folds and more severe respiratory infections such as pneumonia are* Corresponding author. Tel.: +966 503 362 068.
E-mail address: barasheed.o@kamc.med.sa (O. Barasheed).
http://dx.doi.org/10.1016/j.ijid.2016.03.023
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).the leading causes of hospital admission.1–3 Likewise, a number of
inﬂuenza outbreaks were reported during the World Youth Day
2008, a large catholic gathering in Sydney.4 MGs are also linked to
globalisation of various infections. For instance, the Iztapalapa Play
Passion, a religious festival in Mexico, was believed to spark the
outbreak of swine ﬂu leading to its accelerated dissemination across
the world.5 Therefore, international public health agencies, includ-
ing World Health Organization (WHO), have issued guidelines on
mass gathering preparedness to minimise the possible risks.6
From a public health perspective, one of the key concerns is to
prevent global spread of respiratory infections during MGs.
Interventions like vaccinations against viral and bacterial respira-
tory infections, anti-inﬂuenza prophylaxis and hand hygiene areciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
O. Barasheed et al. / International Journal of Infectious Diseases 47 (2016) 105–111106considered as preventive measures but the measures have
limitations. For instance, vaccinations against respiratory infec-
tions, such as inﬂuenza, are recommended for travellers to MGs
such as Hajj,7 and even though a recent systematic review
generally supports its effectiveness against laboratory-conﬁrmed
inﬂuenza at Hajj,8 frequent mismatch between vaccine strains and
circulating strains is an important concern.9 Soaring antiviral
resistance against both adamantanes and neuraminidase inhibi-
tors is an issue that limits their widespread use in MGs.4,10
Similarly, while hand hygiene has been recommended as a
protective measure for attendees of MGs, its effectiveness is not
fully evaluated in a mass gathering setting and the efﬁcacy is
debatable.11 Therefore, the role of another protective measure,
facemask, should be explored in the prevention of respiratory
infections.12 Facemask is believed to have a protective role in
preventing nosocomial infections since the time of Spanish
inﬂuenza.13 Several studies have assessed the usefulness of
facemask in household, community and healthcare settings, the
ﬁndings of which have been summarised in a few reviews.14–16
Noticeable disparities of facemask effectiveness between these
studies were observed. Studies conducted in community or health
care settings found facemasks to be generally effective against
inﬂuenza-like illness (ILI) or even against severe acute respiratory
syndrome (SARS) but its effectiveness against respiratory infec-
tions at MGs remains unknown.15,17 A review of non-pharmaceu-
tical interventions against respiratory tract infections among Hajj
pilgrims presented data on the uptake of facemask and acknowl-
edged that compliance was generally poor, but did not evaluate its
effectiveness during Hajj.11 Subsequently, further data on the
uptake and effectiveness have become available, especially from a
pilot randomised controlled trial (RCT).18 The aim of this
systematic review is to explore the uptake and effectiveness of
facemask against respiratory infections in MGs.Records identified through 
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Figure 1. Flow diagram o2. Methods
Studies were identiﬁed through searching electronic databases
including; Medline (PubMed and Ovid), EMBASE, SCOPUS and
CINAHL from database inception to February 8, 2016. We used a
combination of MeSH terms and text words including: ‘crowding’
OR ‘mass gathering’ OR ‘large event’ OR ‘group assembly’ OR
‘holiday’ OR ‘travel’ OR ‘sport’ OR ‘Olympic’ OR ‘FIFA’ OR ‘festival’
OR ‘Hajj’ (also alternative spelling ‘Hadj’ or ‘Haj’) OR ‘pilgrimage’
AND ‘mask’ OR ‘facemask’ OR ‘surgical mask’ OR ‘medical mask’ OR
‘simple mask’ AND ‘infection’ OR ‘respiratory tract diseases’ OR
‘disease outbreaks’ OR ‘infectious disease’ OR ‘respiratory tract
infections’ OR ‘inﬂuenza’ OR ‘pneumonia’. Additionally, an online
search of pertinent epidemiology journals, including those not
indexed in the mentioned databases (e.g. Saudi Epidemiology
Bulletin) was carried out through free hand Google engine search.
Finally, manual search was performed reviewing reference lists of
included studies to identify additional potentially relevant studies.
The search result was presented according to the preferred
reporting items for systematic reviews and meta-analyses
(PRISMA) guidelines (Figure 1).19
In the ﬁrst phase, three authors (OB, SM and HB) identiﬁed the
potential titles, and sifted the titles and abstracts against
the inclusion criteria. Titles of all studies published in English
language and reported the use or effectiveness of facemask against
respiratory infections in MGs were preliminarily included. Studies
that dealt with attendees of MGs of any age, gender and country
were considered for inclusion. At the end of the screening phase,
full texts of potentially relevant studies were retrieved for detailed
study. Finally studies that met the inclusion criteria were included
for data synthesis. Duplicates were excluded.
Five authors (OB, MA, HB, SM and JA) independently extracted
the data from each study into a data extraction sheet which wasAdditional records identified 
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effectiveness’ and ﬁve authors subsequently cross-checked the
entries (OB, AA, HB, SM and JA),while a sixth author (HR) arbitrated
when a discrepancy occurred. The following data were abstracted
in each extraction sheet: study design, year of conducting the
study, sample size, country of origin, age, gender, diagnostic
method used, deﬁnitions of study end point, and history of
participants’ chronic diseases, if available.
The quality of the included studies were categorised according
to a modiﬁed ranking criteria based on Oxford Evidence Based
Medicine (http://www.cebm.net/) into groups (e.g., A, B, C, D)
where A was for RCTs of adequate sample size, B for observational
studies of adequate sample size with good quality or pilot RCTs or
non-randomised trial, C for observational studies of inadequate
sample size or of poor quality, and D for cases series, such as focus
groups or qualitative surveys.
3. Results
3.1. General description
The search results are summarised in Figure 1. Brieﬂy, of
567 abstracts and titles scanned ultimately 25 studies were
included. All examined facemask uptake; of them, 13 studies also
examined the effectiveness of facemask. The studies were
conducted between 1999 and 2014 involving participants fromTable 1
Characteristics of included studies that examined facemask uptake among Hajj attend
Author Study
year
Study type Study population Gen
fem
Al-Shihry et al35 1999 Cross-sectional 1707 international
pilgrims
NR 
Al-Maghderi et al34 2002 Cross-sectional 1374 international
pilgrims
13.
Zein, U22 2002 Cohort 447 Indonesian pilgrims 63.
Choudhry et al28 2002 Cohort 1027 Saudi Arabia
pilgrims
27 
Aljoudi et al27 2003 Cross-sectional 451 Saudi Arabia
pilgrims
30.
Abdin et al20 2004 Trial 995 Saudi Arabia
pilgrims
43 
Al-Asmary et al24 2005 Case control 250 Saudi Arabia HCWs 12.
Al-Zahrani et al36 2006 Cross-sectional 500 international
pilgrims
10 
Khamis et al38 2007 Cross-sectional 248 international
pilgrims
54.
Deris et al37 2007 Cross-sectional 387 Malaysian pilgrims 43.
Elachola et al21 2009 Cross-sectional international photo
frames
23 
Balaban et al30 2009 Cohort 186 USA pilgrims 50.
Al-Jasser et al26 2009 Cross-sectional 1507 Saudi Arabia
pilgrims
38.
Ahmed et al23 2009 Cohort 126 Saudi Arabia HCWs 20.
Memish et al25 2009 Cross-sectional 104 Saudi Arabia HCWs 15 
Gautret et al33 2009 Cohort 274 French pilgrims 47.
Maslamani et al39 2010 Cross-sectional 1717 international
pilgrims
36.
Emamian et al31 2010 Cohort 95 Iranian pilgrims 42.
Barasheed et al18 2011 RCT 164 Australian pilgrims 56.
Benkouiten et al1 2012 Cohort 137 French pilgrims 61.
Elachola et al21 2013 Cross-sectional International pilgrims 16 
Benkouiten et al2 2013 Cohort 129 French pilgrims 59.
Hashim et al40 2013 Cross-sectional 468 Malaysian pilgrims 43.
Alqahtani et al29 2014 Cohort 25 international
pilgrims
41.
Alqahtani et al41 2009-12 Case series 10 Australian pilgrims 40 
Gautret et al32 2012-14 Cohort 382 French pilgrims 62 
Pooled
estimate
1999-2014 All studies 12710 participants of
55 nations
37.
HCWs, health care workers; NA, not applicable; NR, not reported; RCT, randomised co55 countries. Almost all the included studies involved Hajj pilgrims
or other attendees of Hajj pilgrimage such as health care workers
(HCWs) at Hajj. Four (out of 25) studies purely focused on the use
of facemask against respiratory infections in MGs,18,20–22 the other
21 studies included facemasks as a part of other intervention
measures, or in the context of another research question.
The study sample sizes varied widely ranging from 10 to
1717 participants. The included studies contained the pooled data
of 12710 participants aged between 11 and 89 years (mean age
ranged from 33.5 to 61.7 years in individual studies). About 37% of
the pooled samples were females, in individual studies the
proportion of females ranged from 10% to 63%. Excluding three
studies, which involved HCWs deployed at Hajj,23–25 all other
included studies involved Hajj pilgrims. The origin of the
participants varied depending on the study, seven studies included
multinational participants, while the other 18 were exclusive to
participants from a single country of origin; seven out of 18 (38.9%)
were from Saudi Arabia,20,23–28 According to study types 11 out of
25 were cohort studies,1,2,22–24,28–33 another 11 cross-sectional
studies,21,25–27,34–40 two trials (not necessarily RCTs)18,20 and one
case-series conducted as a qualitative study41 (Table 1).
3.2. Uptake of facemask
The median uptake of facemask in pooled sample was 53.5%.
The lowest reported uptake was 0.02% by Elachola et al. amongees in the last decade
der
ale %
Mean age
(range) years
Chronic
disease %
Facemask
uptake %
Reason for
non-compliance
Ranking
NR NR 24 NR D
6 43 13.2 33.2 NR C
1 52.4 (40-64.8) 40.9 48.4 NR C
33.5 (21.8-45.2) 8.1 53.6 NR C
6 NR NR 35.3 NR D
35.3 (21.6-49) 26 51.3 NR C
8 37 (28.3-45.7) NR 92.8 NR C
43.5 (11-84) NR 59.4 NR C
4 40.1 (22.5-57.7) 39.1 12.1 NR C
9 50.4 (39.4-61.4) NR 72.9 NR C
NR NR 8.4 NR D
5 48.9 (16-89) 16.7 48.9 NR C
3 37.9 (21-83) 18.4 56.5 NR B
6 38.7 (28.9-48.5) - 50 NR C
40.9 (23-59) 15 73.1 NR C
7 58 (23-83) 49.3 79.6 NR C
3 46.2 (34.7-57.7) 27.1 55.4 NR C
1 NR 48.4 60 NR D
7 44.1 (17-80) 22 40.9 Discomfort B
7 59.3 (21-83) 57.5 55.1 NR C
NA NA 0.02 NR D
7 61.7 (34-85) 52.7 53.5 NR C
8 52.5 (42.4- 62.7) 51 68.8 NR C
5 37.1 (21-61) 39 64 Discomfort
and breathing
difﬁculties
D
NR NR 40 NR D
60.6 (22-85) 55.1 53.7 NR C
3 43.5 (11-89) - 49.7 - -
ntrolled trial; USA, United States of America.
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facemasks through photo frames from surveillance camera during
the Hajj in 2013, therefor it is considered as an outlier.21 The
highest uptake was 92.8% observed by Al-Asmary et al. among
health care workers during Hajj in 2005.24 Excluding these two
studies (Elachola et al21 and Al-Asmary et al24), uptake rate among
pilgrims has remained generally steady with gradual increase from
24% in 1999 to 64% in 2014 with minor ﬂuctuations (Figure 2).
Studies involving HCWs reported an uptake from 50% in 2009 to
92.8% in 2005. According to the pilgrims’ country of origin,
Malaysian pilgrims were noticed to be most compliant to using
facemasks (70.9%),37,40 followed by French (60.5%)1,2,32,33 and
Iranians (60%)31 (Table 1).
Only three studies, all involving Australian pilgrims, evaluated
the reasons of compliance (or non-compliance) of using facemask
during Hajj.18,29,41 The most reported reasons for wearing
facemask were to avoid transmission of infectious organisms
and protection from air pollution.29 However, discomfort and
difﬁculty in breathing were the most reported reasons for not
wearing facemask.18,41
3.3. Effectiveness of facemask
Thirteen studies investigated the effectiveness/efﬁcacy of
facemask against respiratory infections, but the endpoints varied
very widely. Most of these studies (9 out of 13) used a combination
of respiratory symptoms (syndromic) as endpoints with varying
deﬁnitions. For instance, acute respiratory infections (ARI) was
used as an endpoint in three studies,20,24,28 ILI in two,18,37 upper
respiratory tract infection (URTI) in two,22,26 respiratory illness in
two30,40 and respiratory tract infections in one.31 However a couple
of studies used only one respiratory symptom as an endpoint:
fever39 and cough.32 Only one study established laboratory-proven
viral infections25 as an endpoint. Deﬁnitions for the endpoints are
detailed in Table 2.
In regards to the effectiveness of facemask, four out of thirteen
studies demonstrated signiﬁcant effect against respiratory infec-
tions,18,20,22,28 two others showed some effect but did not reach
statistical signiﬁcance.25,26 One study assessed its effectiveness
against fever but ruled out its protectiveness,39 and the other six
studies did not show effectiveness but results were not statistically
signiﬁcant.24,30–32,37,40 The pooled data from all studies revealed0
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Figure 2. Facemask uptake rate amongsigniﬁcant protectiveness of facemasks against respiratory infec-
tions in general at Hajj (relative risk [RR] = 0.89, 95% CI: 0.84-0.94,
p < 0.01) (Table 2).
According to the ranking system we used, most of the studies
were of average quality (C) whereas two studies were ranked
above average (B): a pilot RCT18 and a large cross-sectional study,26
the other seven studies were of below average quality (D) either
because of small sample size or poor study quality (Table 1).
4. Discussion
This systematic review shows that the use of facemask among
the attendees of MGs remains essentially unchanged for decades
although exceptionally in one study a very high uptake (about
93%)24 or a very low uptake rate (0.02%)21 has been reported but
such variability can be explained by their unique study designs or
population characteristics. The pooled data of this systematic
review suggest that facemask is generally effective against
respiratory infections at Hajj, however the endpoints varied
widely.
The uptake of facemask among HCWs deployed at Hajj was
generally higher than that among ordinary Hajj pilgrims with
average compliance among HCWs being 72% compared to 46%
among pilgrims. This ﬁnding is similar to what have been found in
other studies that examined the uptake of facemask in other
settings such as health care and community settings. For instance,
the uptake of facemask among HCWs in several studies ranged
from 56.6% to 84.3% (average 70.7%).42–45 On the other hand, the
uptake of facemask among ordinary population in diverse
household and community settings ranged from 38% to 80.7%
(average 55%).46–52 This could be explained by several individual or
organisational factors. For example, HCWs have ﬁrsthand knowl-
edge about the risk of respiratory infections and the role of
preventive measurements in Hajj.25 Similarly, studies in non-MGs
settings showed a positive relationship between HCWs’ knowledge
about the risk of infectious diseases and their compliance to
preventive measures including the use of facemask.53–55 Organisa-
tional factors such as ready availability of facemask in health care
settings, proper training programs and supportive policy of health
care system could have played an important role in improving the
compliance of HCWs to facemask use.54–57 On the other hand,
limited studies explored these individual and organisationalR² = 0.2964
2014201320122011201009 Years
ach study year
h study
e % in each study year)
 Hajj pilgrims from 1999 to 2014.
Table 2
Characteristics of included studies that examined facemask effectiveness against respiratory infections in Hajj
Author Study year Study type Sample size End points; deﬁnitions Relative risk p-Value
Zein, U22 2002 Cohort 446 URTI; diagnosed by clinical symptom such as cough,
fever, sore throat, hoarseness, cold, and by physical
examination
0.30 < 0.01
Choudhry et al28 2002 Cohort 1027 ARI; deﬁned as the presence of one of the constitutional
symptoms (fever, headache, myalgia) along with one of
the local symptoms (running nose, sneezing, throat
pain, cough with/without sputum, difﬁculty breathing)
0.35 < 0.01
Abdin et al20 2004 Trial 994 ARI; deﬁned as the presence of one of the constitutional
symptoms (fever, headache, myalgia) along with one of
the local symptoms (running nose, sneezing, throat
pain, cough with/without sputum, difﬁculty breathing)
0.13 < 0.01
Al-Asmary et al24 2005 Cohort 250 ARI; deﬁned as the presence of one of the constitutional
symptoms (fever, headache, myalgia) along with one of
the local symptoms (running nose, sneezing, throat
pain, cough with/without sputum, difﬁculty breathing)
1.16 0.74
Deris et al37 2007 Cross-sectional 387 ILI; deﬁned as the triad of cough, subjective fever and
sore throat
1.33 0.07
Balaban et al30 2009 Cohort 143 Respiratory illness; deﬁned as the presence of one or
more of the following localising signs or symptoms:
cough, congestion, sore throat, sneezing, or breathing
problems
1.25 0.34
Al-Jasser et al26 2009 Cross-sectional 1507 URTI; deﬁned as one of the constitutional symptoms
(fever, headache, myalgia) along with one of the local
symptoms (running nose, sneezing, throat pain, cough
with/without sputum, difﬁculty breathing)
0.94 0.18
Memish et al25 2009 Cross-sectional 104 Laboratory-proven viral infections by using multiplex
PCR
0.74 0.54
Maslamani et al39 2010 Cross-sectional 1685 Only fever 1.33 < 0.01
Emamian et al31 2010 Cohort 95 RTI; deﬁned as all types of respiratory tract infections
other than the common cold
1.27 0.43
Barasheed et al18 2011 RCT 164 ILI; deﬁned as subjective (or proven) fever plus one
respiratory symptom
0.47 0.02
Hashim et al40 2013 Cross-sectional 468 Respiratory illness; deﬁned as having ILI or at least one
of the non-ILI respiratory symptoms
1.04 0.22
Gautret et al32 2012-14 Cohort 382 Only cough 1.04 0.60
Pooled estimate 2002-14 All studies 7652 - 0.82 < 0.01
ARI, acute respiratory infection; ILI, inﬂuenza-like illness; PCR, polymerase chain reaction; RCT, randomised controlled trial; RTI, respiratory tract infection; URTI, upper
respiratory tract infection.
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educational session on protective measures against respiratory
infections (including facemask) before Hajj was associated with
signiﬁcantly higher uptake of facemasks among pilgrims.18,20,27,36,38
Moreover, adequate accessibility and availability of facemask during
Hajj may enhance the compliance of pilgrims. Abdin et al and
Barasheed et al revealed a higher uptake of facemask among groups
who were provided with sufﬁcient quantity of free facemask (81.3%
versus 33.6%, p < 0.01, and 76% versus 12%, p < 0.01, respective-
ly).18,20 However, reasons for not using facemask during Hajj have
not been explored adequately. While use of facemask at Hajj has
been ofﬁcially recommended by Saudi Ministry of Health since 2014,
it is too early to have a signiﬁcant impact on pilgrims’ practice of
facemask use.58
Although Hajj took place in different seasons (spring, winter and
autumn), the uptake of facemask among Hajj pilgrims during the last
decade remained generally stable (Figure 2). Findings also showed
that there was no signiﬁcant change in facemask uptake among Hajj
pilgrims during the course of inﬂuenza A (H1N1) pandemic outburst
in 2009, and the Middle East respiratory syndrome corona virus
(MERS-CoV) outbreak since 2012. This does not concur with what
has been reported in published studies involving the members of
general public over the several outbreaks of respiratory infections in
non-MG settings.59–64 Those studies showed an increase in
facemask use during the outbreaks due to participants’ perceived
threat of infection. Poor awareness among many pilgrims of
contemporary outbreaks might explain why their uptake of
facemask did not increase even during an ongoing outbreak.65–67
Interestingly, pilgrims of Asian origin (e.g. Malaysians) had higherfacemask uptake compared to pilgrims from other regions.37,40 A
polling study that evaluated the uptake of non-pharmaceutical
measures during the pandemic inﬂuenza A (H1N1) of 2009 found
that participants of Asian origin (e.g. Japan) had the higher facemask
uptake (71%) compared to the uptake of participants of Western or
Latin American origin.68 Presence of several peaks of inﬂuenza
seasons in some Asian countries, overcrowding, dense smog and air
pollution in many cities may explain the higher uptake of facemask
among people from Asian countries;69,70 additionally, cultural
acceptance practice of the population around facemask while in
public may make a difference.68 Focused studies are required to
investigate factors inﬂuencing facemask compliance among atten-
dees of Hajj and other MGs.
In this systematic review, pooled data of facemask effectiveness
showed that participants who used facemask during Hajj are about
20% less likely to suffer from respiratory infections compared to
those who do not use it. This effectiveness of facemask is
inconclusive due to great heterogeneity in study questions,
assessment methods, study designs and qualities, and endpoints.
In regards to the research questions, three out of 13 studies
investigated facemask effectiveness as the primary research
objective: all three studies yielded signiﬁcant results; whereas
only one out of the other 10 studies that assessed facemask as a
secondary or indirect outcome, yielded signiﬁcant results.
Further, there was great heterogeneity in how the frequency
and duration of facemask use were assessed. Although, most of the
studies used a self-reported questionnaire to quantify facemask
uptake among participants, the qualitative descriptive terms that
the studies used (e.g. ‘‘always’’, ‘‘mostly’’, ‘‘sometimes’’ or ‘‘never’’)
O. Barasheed et al. / International Journal of Infectious Diseases 47 (2016) 105–111110may have introduced subjective bias, since qualitative description
varies depending on participants’ perception about the frequency
and duration of use. However, only one study used measurable
criteria in their questionnaires to quantify the number of
facemasks used including the duration (in hours) and frequency
of use, ﬁnding that using facemask more than eight hours per day
was associated with signiﬁcant decrease in ILI symptoms among
Hajj pilgrims.18 Using surveys with more objective options may
decrease bias,71 and provide more accurate estimate of compliance
to facemask use in MGs.
Study designs also may have contributed to variability in
results. For instance, two trials, a pilot RCT and a non-randomised
trial, reported facemask to be signiﬁcantly effective against
respiratory infections at Hajj, whereas only two out of six cohort
studies reported signiﬁcant results. In contrast, none of the cross-
sectional studies yielded signiﬁcant results. This may indicate that
a higher quality study is more likely to produce convincing results.
Finally, facemask effectiveness also differed depending on the
study endpoints. For example, studies that examined effectiveness
of facemask against a single respiratory symptom (such as cough,
sore throat or fever) either ruled out or did not fully support its
effectiveness.32,37,39 This is most likely because singular endpoints
are often prone to subjective biases due to their non-speciﬁcity. In
addition, solitary respiratory symptoms may result from causes
other than infections; for instance, cough may result from
exposure to dust or smoke during Hajj or may be a manifestation
of a chronic respiratory condition of non-infectious aetiology, e.g.,
bronchial asthma.29 On the other hand, most of the studies that
used syndromic criteria (constellation of symptoms) as an
endpoint reported facemasks to be effective against respiratory
infections during Hajj.18,20,22,26,28 This is most likely due to the fact
that syndromic endpoints are more speciﬁc for an illness than a
singular symptom. Only one study used laboratory-conﬁrmed
infection as an endpoint, but its sample size was relatively small
(n = 104) and it failed to demonstrate statistically signiﬁcant
protectiveness of facemasks against respiratory viral infections
among Hajj HCWs.25 Similarly, in non-MG settings, effectiveness of
facemask varied depending on the study endpoint.42–52,72–74Meta-
analysis of RCTs involving facemask in non-MGs showed efﬁcacy
against ILI but not against laboratory-conﬁrmed inﬂuenza.14,15,75
This study is the ﬁrst focussed systematic review that describes
both the uptake and effectiveness of facemasks against respiratory
infections in MGs, and it compiles a data pool of 12710 participants
originating from more than 50 countries. However, the main
limitation is that most of the studies were of ‘average’ or ‘below
average’ quality. There was only one RCT but that was a pilot trial of
small sample size, and there was another ‘trial’ published in a non-
indexed journal that did not report methodological details
including whether and how randomisation was done. As all
included studies were conducted only in the context of Hajj, it is
not possible to generalise the results to other MGs. A large scale
clustered RCT is currently in its ﬁnal phase that will measure the
efﬁcacy of facemasks against both ‘syndromic’ and laboratory-
conﬁrmed viral infections.75 The full results of the trial, once
available, are likely to provide ﬁrmer evidence on the usefulness of
facemask against respiratory infections among attendees of MGs.
In summary, the use of facemask among attendees of a
particular MG (Hajj) remains almost steady with negligible
increase throughout the last decade with an average uptake of
50%. Facemasks seem to be beneﬁcial against certain respiratory
infections during Hajj but not deﬁnitively proven.
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